Dallas, Texas (PRWEB) August 18, 2014
The report titled “Global Antifungal Therapeutics Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of global antifungal therapeutics market with focus on antifungal drug classes – Polyenes, Azoles, Echinocandins and Allylamines. It provides broad coverage of these classes with detailed analysis of drugs and indications in respective classes. It also assesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period (2014-19). Further, key players of the industry such as Merck & Co., Inc., Pfizer Inc., Astellas Pharma Inc. and Noble Corporation SCYNEXIS, Inc. are also profiled in the report.
Segment Coverage: Polyenes, Azoles, Echinocandins and Allylamines
Company Coverage: Merck & Co., Inc., Pfizer Inc., Astellas Pharma Inc. and SCYNEXIS Inc.
Complete report available @ http://www.marketreportsonline.com/351337.html.
Antifungal agents are drugs used for the treatment of fungal infections that can infect almost any part of the body including skin, nails, respiratory tract, urogenital tract and alimentary tract. Treatment of fungal infections currently available in the market can be broadly classified into four major classes of antifungal drugs – Polyenes, Azoles, Allylamines and Echinocandins. Global antifungal market is dominated by systemic antifungal infection.
Over the past several years, there have been high incidences of invasive fungal infections around the globe. In response to this, various antifungal agents with novel action mechanisms, broader action spectrum and fewer side effects have emerged. Growth within global antifungal therapeutics market is driven by high number of cases of fungal infections, rise in number of immune-compromised aged population and various government initiatives in this field. Some of the restraints to market’s growth are growing resistance to antifungal drugs, limitations with antifungal drugs, presence of generics and government regulations in pharmaceutical industry. Major trends prevailing in the industry includes growth in resistant strains and Candida & Aspergillus causing maximum fungal infections.
Purchase a copy of this report @ http://www.marketreportsonline.com/contacts/purchase.php?name=351337.
Major points from Table of Contents (http://www.marketreportsonline.com/351337-toc.html) are listed below:
1. Executive Summary
2. Antifungal Market: An Introduction
3. Global Antifungal Therapeutics Market Analysis
4. Global Antifungal Therapeutics Market Segment by Drug Type
5. Global Antifungal Market: Growth Drivers & Challenges
6. Global Antifungal Market Trends
7. Competitive Landscape: Global Antifungal Market
8. Company Profiles: Global Antifungal Market
List of Tables
List of Figures
Other Related Reports on Pharmaceuticals Market:
Global Breast Cancer Market Report: 2014 Edition (http://www.marketreportsonline.com/349683.html) Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location. The most common risk factors for breast cancer are being female and growing older.
Migraine Partnering 2009-2014 (http://www.marketreportsonline.com/323112.html) The report provides an analysis of migraine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors migraine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
MarketReportsOnline.com is an online database of regional industry research reports, company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the pharmaceuticals industry, MarketReportsOnline.com offers research studies on agriculture, travel & hospitality, food and beverages, consumer goods, environment, energy and power, retail, agriculture, healthcare, advanced materials, medical devices and much more.